Research theme for competitive and other funds (7):
2022 - 2025 ヒト化ボツリヌス毒素抗体の抗体医薬品としての応用
2015 - 2018 Pluripotent embryonal carcinoma cells are available for identifying cellular targets responsible for botulinum neurotoxins
2008 - 2009 Functional analysis of synaptotagmin IIas a receptor for Clostridium botulinum type B neurotoxin expressed neuroendocrine-like cells
2007 - 2008 ボツリヌス神経毒素と新たに発見した受容体構成成分との分子間相互作用の解析
2004 - 2005 Clarification of the occurrence of avian botulism : the approach with molecular biological studies
ボツリヌス毒素に関する研究
Motecular mechanisms of the action of botulinum toxins
Show all
Papers (62):
Hideyuki ARIMITSU, Tomoko KOHDA, Masafumi MUKAMOTO, Masahiro KUSUMOTO. Evaluation of immunochromatographic test of Shiga toxin 2e in enrichment cultures of swine edema disease clinical samples. Journal of Veterinary Medical Science. 2021. 83. 12. 1913-1917
Y. Mukai, I. Shimatani, T. Kohda, T. Sakamoto, S. Kozaki, R. Kaji. Electrophysiological study for assessment of botulinum toxin type A2 compared with type A1 in healthy volunteers. TOXICON. 2013. 68. 117-117
Y. Torii, M. Shinmura, M. Takahashi, T. Kohda, S. Kozaki, S. Nakahira, A. Ginnaga. Immunological difference between botulinum toxin subtypes A1 and A2 using polyclonal antibody. TOXICON. 2013. 68. 100-101